Conditional deletion of Stat3 in mammary epithelium impairs the acute phase response and modulates immune cell numbers during post-lactational regression by Hughes, Katherine et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conditional deletion of Stat3 in mammary epithelium impairs the
acute phase response and modulates immune cell numbers
during post-lactational regression
Citation for published version:
Hughes, K, Wickenden, JA, Allen, JE & Watson, CJ 2012, 'Conditional deletion of Stat3 in mammary
epithelium impairs the acute phase response and modulates immune cell numbers during post-lactational
regression' The Journal of Pathology, vol. 227, no. 1, pp. 106-17. DOI: 10.1002/path.3961
Digital Object Identifier (DOI):
10.1002/path.3961
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
The Journal of Pathology
Publisher Rights Statement:
Re-use of this article is permitted in accordance with the Terms and Conditions set out at
http://wileyonlinelibrary.com/
onlineopen#OnlineOpen_Terms.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
ORIGINAL PAPER
Journal of Pathology
J Pathol 2012; 227: 106–117
Published online 27 January 2012 in Wiley Online Library
(wileyonlinelibrary.com) DOI: 10.1002/path.3961
Conditional deletion of Stat3 in mammary epithelium impairs the
acute phase response and modulates immune cell numbers during
post-lactational regression
Katherine Hughes,1 Julie A. Wickenden,1 Judith E. Allen2 and Christine J. Watson1*
1 Department of Pathology, University of Cambridge, UK
2 Centre for Immunity, Infection and Evolution, and Institute for Immunology and Infection Research, School of Biological Sciences, University of
Edinburgh, UK
*Correspondence to: Christine J. Watson, Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QP, UK.
e-mail: cjw53@mole.bio.cam.ac.uk
Re-use of this article is permitted in accordance with the Terms and Conditions set out at http://wileyonlinelibrary.com/
onlineopen#OnlineOpen_Terms.
Abstract
Mammary gland regression following weaning (involution) is associated with extensive cell death and the
acquisition of an inflammatory signature. Characterizing the interplay between mammary epithelial cells, the
re-emerging stroma and immune cells has implications for the understanding of the pathogenesis of pregnancy-
associated breast cancer. Stat3 has a role in orchestrating cell death and involution, and we sought to determine
whether expression of Stat3 by the mammary epithelium also influences the innate immune environment
and inflammatory cell influx in the gland. We examined mice in which Stat3 is conditionally deleted only
in the mammary epithelium. Distinct sets of genes associated with the acute phase response and innate
immunity are markedly up-regulated during first phase involution in a Stat3-dependent manner. During second
phase involution, chitinase 3-like 1, which has been associated with wound healing and chronic inflammatory
conditions, is dramatically up-regulated by Stat3. Also at this time, the number of mammary macrophages and
mast cells increases per unit area, and this increase is impaired in the absence of epithelial Stat3. Furthermore,
expression of arginase-1 and Ym1, markers of alternatively activated macrophages, is significantly decreased in
the absence of Stat3, whilst iNOS, a marker associated with classically activated macrophages, shows significantly
increased expression in the Stat3-deleted glands. Thus, Stat3 is a key transcriptional regulator of genes associated
with innate immunity and wound healing and influences mammary macrophage and mast cell numbers. The
presence of epithelial Stat3 appears to polarize the macrophages and epithelial cells towards an alternatively
activated phenotype, since in the absence of Stat3, the gland retains a phenotype associated with classically
activated macrophages. These findings have relevance to the study of pregnancy-associated breast cancer and the
role of Stat3 signalling in recruitment of alternatively activated tumour-associated macrophages in breast cancer.
Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
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Introduction
Mammary gland involution comprises the retrograde
change of the organ to its pre-pregnant state following
weaning. Involution is precisely orchestrated and con-
trolled by a number of soluble factors, such as IL-6
cytokine family members leukaemia inhibitory factor
(LIF) [1] and oncostatin M (OSM) [2], together with
transforming growth factor-β3 [3]. Transcription fac-
tors involved in the control of involution include sig-
nal transducer and activator of transcription 3 (Stat3)
[4–6], CCAAT/enhancer binding protein-δ [7] and
nuclear factor-κB (NF-κB) [8].
Mammary gland involution has reversible and irre-
versible phases. During the first phase, milk stasis
and local factors initiate extensive cell death but the
dam retains the potential to recommence lactation. A
subsequent transition to irreversible involution involves
a second wave of cell death, coupled with dramatic
glandular remodelling [9].
Stat3 has a pivotal role in mediating involution and
mice with a mammary-specific conditional deletion of
Stat3 exhibit a notable delay in this process [4,5].
Although mammary Stat3 is expressed throughout
a reproductive cycle, it is specifically activated by
tyrosine phosphorylation transiently on the day of
birth and 6–12 h after weaning. The initial activator
of Stat3 in the mammary gland is LIF [1,10] and
during reversible involution Stat3 regulates lysosomal-
mediated programmed cell death in the mammary
epithelial cells [6]. During the irreversible phase, Stat3
is activated by OSM and its receptor (OSMR). OSMR
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itself is regulated by LIF-induced Stat3, in a positive
feedback loop which ensures continued activation of
Stat3 as LIF levels decline [2,4].
At the onset of involution there is a dramatic up-
regulation of genes associated with the acute phase
response and inflammation [11,13]. As a sub-group of
these genes have a microarray expression profile which
mirrors that of Stat3 activation by phosphorylation
[11,12], it has been suggested, but not demonstrated,
that these genes are Stat3 targets [11].
Macrophages have been highlighted as key players
in the postnatal development of the mammary gland
[14–17], and in remodelling associated with involu-
tion [13,18,19,20]. Macrophage infiltration occurs from
day 3 of involution [13,18,19] and investigators have
described an eight-fold increase in macrophage num-
ber [20]. In parallel to studies emphasizing the role of
macrophages in second phase involution, other authors
have described the acquisition of certain inflammatory
cell characteristics by the mammary epithelial cells
themselves, particularly expression of the lipopolysac-
charide receptor CD14 [13], which may enable epithe-
lial cells to adopt a phagocytic phenotype during invo-
lution [13,21].
Mast cells also have a role in mammary gland
development in both puberty [22] and involution [23].
Mast cell granules contain plasma kallikrein, consid-
ered the dominant plasminogen activator during mam-
mary involution [23]. Mice in which plasma kallikrein
activity has been inhibited exhibit a delay in involu-
tion, manifested by retarded epithelial cell death and
delayed re-emergence of adipocytes [23].
Given the up-regulation of acute phase response
genes in first phase involution and the increase in
inflammatory cell numbers seen in second phase invo-
lution, the process of mammary gland regression post-
weaning has been likened to a wound-healing response
[13]. There is a well-established association between
inflammation and neoplastic transformation in many
organ systems [24], and it has been recently demon-
strated in a mouse model that the inflammatory envi-
ronment of the mammary gland during involution
has pro-tumourigenic potential [25–28]. Human epi-
demiological evidence demonstrates that for the first
3–5 years post partum, there is a transient increase in
risk of breast cancer [29–31], with this risk increas-
ing for women who delay their first pregnancy until
35 years of age or more [32]. The clinical term
‘pregnancy-associated breast cancer’ (PABC), is vari-
ably defined as mammary neoplasia which is diag-
nosed during pregnancy or up to 1–5 years post partum
[30,33,34]. A subset of cases of PABC arise in the
immediate post-partum period, and these patients are
considered to have the worst prognosis [35].
Understanding the tissue remodelling and inflamma-
tory changes which occur during involution is clearly
crucial to the understanding of the pathogenesis of
PABC. Given the pivotal role for Stat3 in orchestrating
mammary regression post-weaning, we hypothesized
that mammary epithelial expression of Stat3 will influ-
ence the gland’s inflammatory signature. To test this
assertion, we have used mice with a conditional mam-
mary epithelial deletion of Stat3.
Materials and methods
Animal husbandry
Mice carrying the Stat3 gene flanked by loxP sites [36]
were crossed with a strain containing a β-lactoglobulin
promoter-driven Cre gene [37], as previously described
[6]. Mouse husbandry, induction of involution and tis-
sue collection were as previously described [6]. At
least three mice were used for each time point in
every experiment, except in Figure 6C (two mice/time
point). All animals were treated according to local
ethical committee and UK Home Office guidelines.
Tissues from mice with deletion of the OSM recep-
tor (OSMR−/−) [2] were a generous gift from Dr
Richard Clarkson, School of Biosciences, University
of Cardiff, UK.
Microarray analysis
Previously published Affymetrix microarray data was
used to compare mammary tissue from 12 developmen-
tal stages [12].
Histology
Tissue for sectioning was harvested from the abdomi-
nal glands, and was fixed for 24 h in 4% formaldehyde
in PBS (Sigma), sectioned and stained with haema-
toxylin and eosin (H&E) or toluidine blue, following
standard protocols.
Immunofluorescence
Immunofluorescence was carried out on sections of
paraffin-embedded tissue, as previously described [38].
The following primary antibodies were used: anti-
CD14 (AbCam 25 092); anti-E-cadherin (BD Bio-
sciences 610 182); anti-liver arginase 1 (AbCam
91 279); anti-iNOS (Thermo-Fisher Scientific PA1-
036); and anti-Ym1 [39].
Immunohistochemistry
Paraffin-embedded sections were deparaffinized in
xylene, rehydrated in decreasing concentrations of
ethanol and washed in distilled water, phosphate-
buffered saline (PBS), 0.5% Triton PBS, and PBS.
Endogenous peroxidase activity was quenched by incu-
bation in 0.3% hydrogen peroxide (Sigma). Trypsin
antigen retrieval was employed (AbCam). Sections
were blocked sequentially in 5% rabbit serum and
avidin D and biotin block (both from Vector Laborato-
ries). Sections were incubated overnight at 4 ◦C with rat
anti-F4/80 (AbCam 6640) or negative control rat IgG,
both in 2% rabbit serum in PBS. Biotin-conjugated
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polyclonal rabbit anti-rat IgG secondary antibody was
used (AbCam 6733-1). The avidin and biotinylated
horseradish peroxidase macromolecular complex tech-
nique (Vectastain ABC Kit; Vector Laboratories) with
peroxidase substrate (Zymed Laboratories, Invitrogen)
was used for immunohistochemical visualization and
the sections were counterstained with haematoxylin.
Quantitative RT–PCR (qRT–PCR)
RNA extraction, complementary DNA synthesis and
qRT–PCR were carried out as previously described
[40]. Expression levels of selected genes were mea-
sured. Primer sequences are detailed in Table S1 (see
Supporting information).
Immunoblotting
Sample preparation and immunoblotting were carried
out as previously described [41]. The following anti-
bodies were used: anti-phospho-Stat3 (Tyr705; Cell
Signalling Technologies 9131); anti-Stat3 (BD Trans-
duction Laboratories, 610 190); anti-chitinase 3-like
1 (R&D Systems, MAB2649); anti-liver arginase 1
(AbCam 91 279); and anti-β-actin (AbCam 8227).
Cell culture
EpH4 cells were grown in Dulbecco’s modified Eagle’s
medium (DMEM; Gibco) containing 10% fetal calf
serum (FCS; Sigma). At 50% confluence, the cells
were stimulated with a final concentration of 25 ng/ml
recombinant mouse oncostatin M (495-MO; R&D
Systems) or carrier (0.0001% BSA in PBS), and protein
was prepared from cell lysates.
Results
Stat3 regulates expression of genes associated with
the acute phase response in first phase involution
Previously published Affymetrix microarray data [12]
indicate that there is a dramatic up-regulation of numer-
ous genes associated with the acute phase response
and inflammation at the onset of involution. These
include acute phase response genes orosomucoids 1
and 2 (Orm1 and 2), the immunomodulatory secretory
leukocyte protease inhibitor (Slpi), CD14 and leucine-
rich α2-glycoprotein 1 (Lrg1) [42] (Figure 1A, B).
In order to determine whether Stat3 activity influ-
enced the expression of genes associated with the
acute phase response, we compared mice with a
mammary-specific conditional deletion of Stat3
(Stat3fl/fl; BLG–Cre, hereafter called Stat3 KO) to
mice with the Stat3 allele flanked by loxP sites but
with no expression of Cre (Stat3fl/fl, hereafter called
control). Using qRT–PCR, we analysed expression of
the panel of acute phase response genes from mam-
mary tissue. At 24 and 48 h of involution, expression
of Orm1 and 2, Slpi and Lrg1 is significantly reduced
in the Stat3 KO tissue (Figure 1C, D). This finding
is notable, as it suggests that Stat3, expressed by the
mammary epithelial cells themselves, is responsible
for the acute phase response and regulation of the
inflammatory environment of the gland during early
involution.
CD14 is expressed at the apical surface of the mam-
mary luminal epithelial cells from 24 h and throughout
the first 4 days of involution, as previously described
[13]. However, this expression is not detected in the
absence of Stat3 (Figure 1E; see also Supporting infor-
mation, Figure S1A–D). Although CD14 expression is
most commonly associated with macrophages and den-
dritic cells, previous investigators have suggested that
luminal mammary epithelial CD14 expression during
involution indicates acquisition of a phagocytic pheno-
type [13], which may facilitate epithelial cell clearance
of shed cells from the alveolar lumina [21]. Our data
suggest that the up-regulation of CD14 expression is an
essential component of the Stat3 cell death involution
programme, and that epithelial cells lacking intact Stat3
signalling pathways may have an impaired capacity for
efferocytosis.
Interestingly, although at 24 h of involution expres-
sion of CD14 mRNA is significantly reduced in the
Stat3 KO tissue (Figure 1C), this is not the case at
48 h (Figure 1D) or 96 h (authors’ unpublished data),
in spite of the strong association between Stat3 activity
and CD14 protein expression observed by immunofluo-
rescence (see Supporting information, Figure S1B–D).
This suggests that post-transcriptional mechanisms are
likely to be important in the regulation of CD14 expres-
sion by Stat3.
Stat3 regulates expression of chitinase 3-like 1
(Chi3L1), a gene associated with wound healing, in
second phase involution
As we observed dramatic regulation of expression of
acute phase response genes by Stat3 in the first phase
of involution, we wished to explore the potential Stat3
target genes associated with the chronic inflammatory
‘wound-healing signature’ in its second phase. Chi3L1
(synonym: BRP-39) and the human homologue YKL-
40, is a protein originally identified in mouse breast
cancer cells, which has been associated with a range
of chronic inflammatory and allergic conditions and
wound healing [43]. Expression has been associated
with macrophages, neutrophils and fibroblasts [43].
Since Chi3L1 expression was suggested to be up-
regulated during involution by microarray analysis
[13], we wished to investigate a potential connection
with Stat3 activity.
Expression of Chi3L1 mRNA is significantly re-
duced in Stat3 KO animals at 48 and 96 h of involution
(Figure 2A). Chi3L1 protein expression is observed
from 48 h of involution in control mice but expression
is undetectable in the Stat3 KO animals (Figure 2B).
This is interesting, as 48 h marks the switch point to
irreversible involution in mice [44] and is the point at
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Figure 1. Acute phase response genes are up-regulated in first phase involution and a subset of these genes are Stat3-regulated. Table
(A) and microarray expression data (B) detailing genes associated with innate immunity and the acute phase response which show a
dramatic increase in expression in the first phase of involution. Microarray profiles were derived from 12 different time points in the
developmental cycle of the mouse mammary gland; V, virgin; dG, days of gestation; dL, days of lactation; hI, hours of involution. Expression
of selected genes associated with the acute phase response and innate immunity at 24 h (C) and 48 h (D) of involution in control and
Stat3 KO mice, measured by qRT–PCR relative to expression of cyclophilin (a housekeeping gene); values are mean ± standard deviation
(SD) from at least three biological repeats; ∗p < 0.05, ∗∗∗p < 0.001, as determined by Student’s t-test. (E) Immunofluorescence staining
for CD14 (red), E-cadherin (green) and DNA (Hoechst; blue) on control and Stat3 KO tissue at 24 h of involution; scale bars = 10 μm.
Copyright © 2012 Pathological Society of Great Britain and Ireland. J Pathol 2012; 227: 106–117
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Figure 2. Chitinase 3-like 1 (Chi3L1) is up-regulated at the onset of the second phase of involution in a Stat3-dependent manner.
(A) Expression of Chi3L1 in control and Stat3 KO mice at 48 and 96 h of involution measured by qRT–PCR relative to expression of
cyclophilin (a housekeeping gene); values are mean ± SD from at least four biological repeats; ∗∗p < 0.01, ∗∗∗p < 0.001, as determined
by Student’s t-test. (B) Representative western blot analysis, showing Chi3L1 and β-actin expression at 10 days of lactation (10 dL) and
during involution with control and Stat3 KO tissues; h, hours of involution. (C) Expression of Chi3L1 in control (OSMR Het) and OSMR KO
mice at 48 and 96 h of involution, measured by qRT–PCR relative to expression of cyclophilin (a housekeeping gene); values are mean ±
SD from at least three biological repeats; ∗p < 0.05, as determined by Student’s t-test. (D) Representative western blot analysis, showing
expression of Chi3L1, phosphorylated Stat3 (pStat3), total Stat3 (tStat3) and β-actin at 10 dL and in involution with control (OSMR Het)
and OSMR KO tissues; h, hours of involution; d, days of involution. (E) Western blot analysis of mammary epithelial EpH4 cells, stimulated
with oncostatin M (OSM) or vehicle alone (control) for the indicated number of hours; blot is representative of two experimental repeats.
(F) Quantification of two western blots illustrating Chi3L1 expression relative to tStat3, following 24 h of treatment of EpH4 cells with
OSM or vehicle alone (control).
which the phenotype of the gland becomes increasingly
similar to a healing wound.
As the cytokine oncostatin M (OSM) is the principal
activator of Stat3 in second phase involution, we
investigated expression of Chi3L1 in mice with total
deletion of the OSM receptor (OSMR) [2] (Figure 2C,
D). At 48 h of involution, levels of Chi3L1 mRNA and
protein do not differ between control mice and those
with deletion of OSMR (OSMR KO) (Figure 2C, D),
which is consistent with the observation that the OSMR
KO mice have unperturbed Stat3 activity for the first
2 days of involution [2], when LIF signalling is the
predominant activator of Stat3 [10]. However, at 96 h
of involution, mRNA and protein expression of Chi3L1
is notably reduced in OSMR KO mice (Figure 2C,
D), a profile consistent with the abrogation of Stat3
activity in the OSMR KO mice as LIF levels decline
in second phase involution [10] and OSM becomes the
principal activator of Stat3 [2]. Additionally, mammary
epithelial EpH4 cells stimulated with OSM for 24 h to
activate Stat3 exhibit increased expression of Chi3L1
compared to those cells stimulated with vehicle alone
(Figure 2E, F).
Taken together, these results suggest that Chi3L1 is
downstream of Stat3 signalling induced by OSM in
second-phase involution. However, by 6 days of invo-
lution, levels of Chi3L1 are comparable between con-
trol and OSMR KO animals, although pStat3 expres-
sion is negligible in the latter (Figure 2D). This is
interesting, as it suggests that Stat3 is not the sole
regulator of Chi3L1 expression in mammary gland
involution. Further evidence of this is the finding that
Stat3 KO mice will express Chi3L1 if pups are returned
to the dam following 48 h of involution (authors’
unpublished data). Given the established role of NF-
κB in regulation of involution [8], and as this tran-
scription factor has been suggested to regulate secre-
tion of Chi3L1 in chondrocytes [45], we hypothesize
that NF-κB may influence Chi3L1 expression in later
involution.
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Figure 3. In the absence of epithelial Stat3, the increase in numbers of macrophages and mast cells during involution is diminished.
(A) Immunohistochemical staining for F4/80 to identify murine macrophages (arrows) in control and Stat3 KO glands at 96 h of involution;
scale bars = 10 μm. (B) Quantification of macrophages per ×1000 field. A minimum of 20 fields and three mice were analysed per time
point; values are mean ± SD from at least three biological repeats; ∗p < 0.05, ∗∗p < 0.01, as determined by Student’s t-test. (C) Toluidine
blue staining for mast cells (arrows) in control and Stat3 KO glands at 72 h of involution; scale bars = 50 μm; inset shows mast cells at
×1000 magnification. (D) Quantification of mast cells per ×400 field; a minimum of 20 fields and 3 mice were analysed per time point;
values are mean ± SD from at least three biological repeats; ∗p < 0.05, as determined by Student’s t-test.
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Figure 4. At 96 h of involution, expression of matrix metallopro-
teinase enzymes 2, 3 and 9 is down-regulated in the absence of
epithelial Stat3. Expression of matrix metalloproteinases 2, 3 and
9 (MMP2, MMP3 and MMP9) and prekallikrein (Klkb1) in control
and Stat3 KO mice at 96 h of involution measured by qRT–PCR
relative to expression of cyclophilin (a housekeeping gene); values
are mean± SD from five biological repeats; ∗p < 0.05, ∗∗p < 0.01,
as determined by Student’s t-test.
In the absence of epithelial Stat3 during involution,
the number of macrophages and mast cells is
diminished
Having observed that Stat3 has a pivotal role in
control of the inflammatory environment of the gland
during involution, we wished to consider whether the
diminished inflammatory gene expression signature in
Stat3 KO mice influenced the number of immune
cells present. In order to investigate the fluctuations in
macrophage and mast cell numbers within the gland,
we performed immunohistochemical staining for F4/80
and histochemical staining with toluidine blue for
macrophages and mast cells, respectively.
There are significantly more macrophages per unit
area in control mice at 96 h compared to 72 h invo-
lution, with a more than six-fold increase in num-
bers between these time points (Figure 3A, B). This
is in accordance with previously published data,
allowing for strain variations between rodent models
[13,18,19,20]. The increase in macrophage numbers is
seen during the second phase of involution, when the
gland becomes irreversibly committed to a profound
degree of matrix remodelling and cell death. It is likely
that the role of macrophages encompasses both stromal
reorganization and phagocytosis of cellular remnants.
The increase in macrophage numbers per unit area is
more modest in the Stat3 KO glands, and at 96 h con-
trol glands have significantly more macrophages than
those lacking epithelial Stat3 (Figure 3A, B).
Mast cells are also present in the gland throughout
involution and there are increased numbers of mast
cells at 96 h of involution compared to 10 days lacta-
tion in control glands. However, in Stat3 KO glands
there are significantly reduced numbers of mast cells
at 72 h of involution (Figure 3C, D).
The decrease in numbers of macrophages and mast
cells in Stat3 KO glands compared to controls at 96 h
and 72 h involution, respectively, is interesting as it
suggests that epithelial Stat3 is either directly or indi-
rectly influencing the numbers of these immune cells
in the gland during the irreversible phase of involution.
This may be a consequence of reduced expression of
cytokines and/or chemokines by the epithelium, or lack
of appropriate feed-forward mechanisms from resident
tissue macrophages and mast cells within the mammary
gland, due to reduced numbers of dead epithelial cells.
In the absence of epithelial Stat3, expression of
matrix metalloproteinases 2, 3 and 9 is significantly
reduced
Macrophages have previously been demonstrated to
reshape the stromal architecture via elaboration of
matrix metalloproteinases (MMPs) [18], and we there-
fore considered it likely that a reduction in expression
of matrix metalloproteinases from diminished numbers
of macrophages would contribute to the delayed invo-
lution phenotype seen in Stat3 KO glands. In order
to test this hypothesis, we used qRT–PCR to measure
expression of MMPs 2, 3 and 9 at 96 h of involution,
and demonstrated a significant reduction in expression
of these enzymes in the Stat3 KO glands (Figure 4).
Our results are in accordance with an earlier study
demonstrating reduced expression of MMP3 in OSMR
KO mice [2].
Given that plasminogen-deficient mice exhibit de-
layed involution [46], and that the predominant mam-
mary plasminogen activator during involution (plasma
kallikrein) localizes to mammary mast cells [23], we
wished to investigate whether the reduction in mast
cell numbers observed in the Stat3 KO mice has
an effect on expression of the prekallikrein gene
(Klkb1). Although Klkb1 expression measured at 96 h
of involution by qRT–PCR does not differ signifi-
cantly between control and Stat3 KO glands, there is a
trend towards reduced expression in the Stat3 KO ani-
mals (Figure 4). Interestingly, we observe considerable
mouse-to-mouse variation in expression of Klkb1.
iNOS expression is increased in second phase
involution in the absence of epithelial Stat3 activity
In order to investigate the phenotype of the involution
macrophages, we used qRT–PCR and immunofluores-
cence to analyse expression of iNOS [associated with
a classically activated (M1) macrophage phenotype]
[47]. At 10 days of lactation, mRNA levels of iNOS
are not significantly different between control and Stat3
KO glands (see Supporting information, Figure S5). At
96 h of involution, mRNA levels for iNOS are signif-
icantly elevated in the Stat3 KO tissue (Figure 5A),
suggesting that absence of epithelial Stat3 favours
polarization towards an M1 phenotype. In both control
and Stat3 KO glands, iNOS expression predominantly
localizes to the cytoplasm of cells, with location and
morphology consistent with macrophages (Figure 5B;
see also Supporting information, Figure S2).
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Figure 5. Absence of epithelial Stat3 activity increases iNOS expression during involution. (A) Expression of inducible nitric oxide
synthetase (iNOS) at 96 h of involution in control and Stat3 KO mice, measured by qRT–PCR relative to expression of cyclophilin (a
housekeeping gene); values are mean ± SD from at least three experimental repeats, with each bar representing an individual mouse;
∗p < 0.05, as determined by Student’s t-test. (B) Immunofluorescence staining for iNOS (red), E-cadherin (green) and DNA (Hoechst; blue)
at 96 h of involution on control and Stat3 KO tissue. Arrows indicate cytoplasmic iNOS expression within cells with morphology consistent
with macrophages; scale bars = 100 μm.
Epithelial Stat3 expression influences polarization
to an alternatively activated macrophage
phenotype during involution
As macrophages with an alternatively activated (M2)
phenotype have been observed in involution [20], we
wished to investigate whether Stat3 activity influenced
this M2 polarization. To achieve this, we examined the
expression of arginase-1 and Ym1 (associated with a
murine macrophage M2 phenotype) [47]. At 10 days
of lactation, mRNA levels of both markers are similar
between control and Stat3 KO glands (see Supporting
information, Figure S5). However, at 96 h of involu-
tion, control tissue expresses significantly higher levels
of arginase-1 than the Stat3 KO glands (Figure 6A–D).
There are moderate levels of arginase-1 expression in
macrophages and surprisingly high levels of arginase-
1 expression in mammary epithelial cells. In Stat3
KO glands, arginase-1 is minimally detectable in the
cytoplasm of macrophages and only occasional epithe-
lial cells exhibit expression (Figure 6A; see also Sup-
porting information, Figure S3). Similarly, at 96 h of
involution, control tissue expresses significantly higher
levels of Ym1 than the Stat3 KO glands (Figure 6E,
F). Both mammary epithelial cells and macrophages
express Ym1 in control glands and reduced levels
of expression are observed in macrophages in Stat3
KO glands, although the level of epithelial expression
remains high (Figure 6E; see also Supporting informa-
tion, Figure S4).
The cytokines IL-4 and IL-13 have been implicated
in the acquisition of an M2 phenotype [47] and an
increase in levels of both IL-4 and IL-13 has been
observed during involution in rats [20]. Accordingly,
we used qRT–PCR to investigate the expression of IL-
4 receptor-α in control and Stat3 KO glands at 96 h of
involution, and demonstrated a significant reduction in
expression of IL-4 receptor-α in the Stat3 KO glands
(Figure 6G).
Taken together, these results suggest that the absence
of epithelial Stat3 modulates both macrophage and
mammary epithelial cell acquisition of an M2 pheno-
type during involution. It is possible that this polar-
ization is achieved through regulation of expression of
IL-4 receptor-α, although this requires further experi-
mental investigation.
Discussion
Using mice with a mammary epithelial- and lactation-
specific Stat3 deletion, we have demonstrated that
epithelial expression of Stat3 is critical for the induc-
tion of an inflammatory gene expression signature dur-
ing involution. In the first phase of involution, Stat3
dramatically modulates expression of genes associated
with the acute-phase response and innate immunity,
and in the second phase, Stat3 regulates expression
of chitinase 3-like 1, which is associated with chronic
inflammation and wound healing [43].
It is interesting to note that during involution there
are complex and overlapping roles for the epithelial
and immune cell compartments. We have previously
established that mammary epithelial cells undergo a
transition from Th1 to Th2 cytokine production upon
the induction of differentiation during development
[41]. Similarly, in the present study we demonstrate
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Figure 6. Epithelial Stat3 activity influences polarization to an alternatively activated macrophage phenotype during involution.
(A) Immunofluorescence staining for arginase-1 (red), E-cadherin (green) and DNA (Hoechst; blue) at 96 h of involution on control and
Stat3 KO tissue. Arrows indicate arginase-1 expression within cells with morphology consistent with macrophages; scale bars = 20 μm.
(B) Expression of arginase-1 (Arg1) at 96 h of involution in control and Stat3 KO mice, measured by qRT–PCR relative to expression of
cyclophilin (a housekeeping gene); values are mean ± SD from at least three experimental repeats, with each bar representing an individual
mouse; ∗p < 0.05, as determined by Student’s t-test. (C) Representative western blot analysis of two independent biological samples,
showing arginase-1 (Arg1) and β-actin expression at 10 days of lactation (10 dL) and in involution with control and Stat3 KO tissues
(values indicate hours of involution). (D) Quantification of western blot from Figure 6C, illustrating Arg1 expression relative to β-actin at
96 h of involution. (E) Immunofluorescence staining for Ym1 (red), E-cadherin (green) and DNA (Hoechst; blue) at 96 h of involution on
control and Stat3 KO tissue. Arrow indicates Ym1 expression within a cluster of cells adjacent to a blood vessel, which have morphology
consistent with macrophages; scale bars = 20 μm. (F) Expression of Ym1 at 96 h of involution in control and Stat3 KO mice measured
by qRT–PCR relative to expression of cyclophilin (a housekeeping gene); values are mean ± SD from at least three experimental repeats,
with each bar representing an individual mouse; ∗p < 0.05, as determined by Student’s t-test. (G) Expression of IL-4 receptor-α at 96 h
of involution in control and Stat3 KO mice, measured by qRT–PCR relative to expression of cyclophilin (a housekeeping gene); values are
mean ± SD from five biological repeats; ∗p < 0.05, as determined by Student’s t-test.
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that epithelial Stat3 expression during involution drives
a polarization of the epithelial and immune cell com-
ponents of the gland towards an M2 phenotype.
Our results also give insights into mammary remod-
elling during involution. Other investigators have pre-
viously demonstrated mammary epithelial expression
of CD14 and related this expression to acquisition of
a phagocytic phenotype by the luminal epithelial cells
[13]. Here, we demonstrate the CD14 expression by
mammary epithelial cells is critically dependent on
Stat3 activity. As Stat3-dependent CD14 expression
occurs as early as 24 h of involution, it would seem
that epithelial efferocytosis may be an important mech-
anism for clearance of dead epithelial cells early in the
first phase, when dying cells are shed into the alveolar
lumen. At this stage, the shed cells are most likely inac-
cessible to macrophages, as the alveolar units appear
largely intact by light microscopy. Later, as the num-
ber of macrophages within the gland increases, it seems
likely that these professional phagocytes will clear cel-
lular debris, particularly as the alveolar units collapse
and structural integrity is lost, allowing macrophages
unimpeded access to dying cells. As epithelial CD14
expression persists through the first 4 days of involu-
tion in control glands, we cannot discount an ancillary
role for mammary epithelial cell-mediated efferocytosis
during the irreversible phase.
In the absence of epithelial Stat3, reduced num-
bers of mast cells and macrophages are present at 72
and 96 h of involution, respectively. Given the fun-
damental role of Stat3 activity in up-regulating the
early involution acute phase response, it is possible
that immune cell recruitment is directly dependent on
epithelial Stat3. However, it is also possible that the
reduction in numbers of macrophages and mast cells in
the absence of epithelial Stat3 may reflect an indirect
effect of Stat3 signalling, viz a delay in restructur-
ing the gland when Stat3 is conditionally deleted. The
exact directionality of the relationship between Stat3
signalling, mammary remodelling and the increase in
numbers of macrophages and mast cells is difficult to
determine, particularly given that both epithelial cells
[48] and macrophages [18] may elaborate matrix met-
alloproteinases responsible for stromal restructuring.
We have demonstrated that epithelial Stat3 activ-
ity has a direct or indirect effect upon both epithe-
lial and macrophage expression of markers of an M2
macrophage phenotype during involution. This has
important implications for the understanding of inter-
actions between tumour-associated macrophages and
neoplastic epithelial cells, particularly given that many
breast tumours exhibit constitutive activation of Stat3
[11]. We hypothesize that Stat3 signalling within neo-
plastic breast epithelial cells themselves may be impor-
tant for the recruitment of macrophages and polariza-
tion of these cells towards an M2 phenotype.
Finally, our results demonstrate that Stat3 signalling
during both phases of the involution process is critical
for the expression of an inflammatory signature within
the gland. As it is this inflammatory signature which
is considered to be the cause of the increased risk of
occurrence of breast cancer in the period immediately
post-weaning [25–28], we suggest that epithelial Stat3
expression is at the very heart of the pathogenesis of
pregnancy-associated breast cancer.
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SUPPORTING INFORMATION ON THE INTERNET
The following supporting information may be found in the online version of this article:
Figure S1. Expression of CD14 is Stat3 regulated throughout the first 4 days of involution.
Figure S2. iNOS is expressed by macrophages during involution.
Figure S3. Epithelial Stat3 influences expression of arginase-1 during involution.
Figure S4. Epithelial Stat3 influences expression of Ym1 during involution
Figure S5. Expression of inducible nitric oxide synthase, arginase-1 and Ym1 does not vary between control and Stat3 KO mice at 10 days
of lactation
Table S1. Primers used for quantitative RT–PCR analysis.
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